Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dapsone gel 5% in the treatment of mild to moderate acne
IRCT20220724055546N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dapsone in acne vulgaris, sponsored by Hamadan University of Medical Sciences. Started Aug 2022; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20220724055546N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220724055546N1.